SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $30,036,000 | -10.6% | 532,164 | -1.9% | 0.04% | -2.4% |
Q4 2021 | $33,612,000 | -4.9% | 542,316 | -2.6% | 0.04% | -4.7% |
Q3 2021 | $35,333,000 | -24.2% | 556,940 | -1.5% | 0.04% | -23.2% |
Q2 2021 | $46,609,000 | +9.8% | 565,578 | -2.0% | 0.06% | +1.8% |
Q1 2021 | $42,452,000 | +1.1% | 577,032 | -0.3% | 0.06% | -1.8% |
Q4 2020 | $41,993,000 | +51.3% | 579,044 | -0.6% | 0.06% | +40.0% |
Q3 2020 | $27,758,000 | +54.2% | 582,287 | +35.8% | 0.04% | +37.9% |
Q2 2020 | $18,003,000 | – | 428,644 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |